These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1964202)

  • 21. Multiple sclerosis: TNF revisited, with promise.
    Raine CS
    Nat Med; 1995 Mar; 1(3):211-4. PubMed ID: 7585035
    [No Abstract]   [Full Text] [Related]  

  • 22. Alterations in the binding of the phosphodiesterase inhibitor, rolipram, after transient ischemia in the gerbil brain.
    Asanuma M; Ogawa N; Hirata H; Kondo Y; Nishibayashi S; Yamamoto M; Mori A
    Res Commun Chem Pathol Pharmacol; 1993 Dec; 82(3):279-85. PubMed ID: 8122028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of spasmogen-stimulated Ins(1,4,5)P3 generation and functional responses by selective inhibitors of types 3 and 4 phosphodiesterase in airways smooth muscle.
    Challiss RA; Adams D; Mistry R; Nicholson CD
    Br J Pharmacol; 1998 May; 124(1):47-54. PubMed ID: 9630342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of a cardiotonic quinolinone derivative Y-20487 on the isoproterenol-induced positive inotropic action and cyclic AMP accumulation in rat ventricular myocardium: comparison with rolipram, Ro 20-1724, milrinone, and isobutylmethylxanthine.
    Katano Y; Endoh M
    J Cardiovasc Pharmacol; 1992; 20(5):715-22. PubMed ID: 1280732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Congenital nephrogenic diabetes insipidus with bilateral hydronephrosis: indomethacin in treatment of nephrogenic diabetes insipidus.
    Sohn YM; Lee C; Kim PK; Yun DJ
    Yonsei Med J; 1980; 21(2):116-22. PubMed ID: 7314648
    [No Abstract]   [Full Text] [Related]  

  • 26. Diabetes Insipidus.
    Lu HA
    Adv Exp Med Biol; 2017; 969():213-225. PubMed ID: 28258576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Chlorpropamide in diabetes insipidus].
    Uhlich E; Loeschke K
    Minerva Med; 1973 May; 64(31):1702-4. PubMed ID: 4351789
    [No Abstract]   [Full Text] [Related]  

  • 28. Involvement of cyclic nucleotide-dependent protein kinases in cyclic AMP-mediated vasorelaxation.
    Eckly-Michel A; Martin V; Lugnier C
    Br J Pharmacol; 1997 Sep; 122(1):158-64. PubMed ID: 9298542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rolipram inhibits staphylococcal enterotoxin B-mediated induction of the human skin-homing receptor on T lymphocytes.
    Santamaria LF; Torres R; Giménez-Arnau AM; Giménez-Camarasa JM; Ryder H; Palacios JM; Beleta J
    J Invest Dermatol; 1999 Jul; 113(1):82-6. PubMed ID: 10417623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Congenital nephrogenic diabetes insipidus].
    Thibonnier M
    Rev Prat; 1994 May; 44(9):1169-72. PubMed ID: 7939338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of phosphodiesterase IV and intracellular calcium levels in human polymorphonuclear leukocytes.
    Villagrasa V; Navarrete C; Sanz C; Berto L; Perpiñá M; Cortijo J; Morcillo EJ
    Methods Find Exp Clin Pharmacol; 1996 May; 18(4):239-45. PubMed ID: 8803956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphodiesterase inhibitors may be indicated in the treatment of postulated vasoactive neuropeptide autoimmune fatigue-related disorders.
    Staines DR
    Med Hypotheses; 2006; 66(1):203-4. PubMed ID: 16171950
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of inhibitors of phosphodiesterase, on antigen-induced bronchial hyperreactivity in conscious sensitized guinea-pigs and airway leukocyte infiltration.
    Danahay H; Broadley KJ
    Br J Pharmacol; 1997 Jan; 120(2):289-97. PubMed ID: 9117122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is phosphodiesterase inhibition a new mechanism of antidepressant action? A double blind double-dummy study between rolipram and desipramine in hospitalized major and/or endogenous depressives.
    Bobon D; Breulet M; Gerard-Vandenhove MA; Guiot-Goffioul F; Plomteux G; Sastre-y-Hernández M; Schratzer M; Troisfontaines B; von Frenckell R; Wachtel H
    Eur Arch Psychiatry Neurol Sci; 1988; 238(1):2-6. PubMed ID: 3063534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PGE1 and prostacyclin suppression of NK-cell mediated cytotoxicity and its relation to cyclic AMP.
    Lanefelt F; Ullberg M; Jondal M; Fredholm BB
    Med Biol; 1983; 61(6):324-30. PubMed ID: 6328136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of rolipram and cilostamide on renal functions and cyclic AMP release in anesthetized dogs.
    Tanahashi M; Hara S; Yoshida M; Suzuki-Kusaba M; Hisa H; Satoh S
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1533-8. PubMed ID: 10336549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delayed stimulation of bone resorption in vitro by phosphodiesterase inhibitors requires the presence of adenylate cyclase stimulation.
    Ransjö M; Fredholm BB; Lerner UH
    Bone Miner; 1988 Jan; 3(3):225-34. PubMed ID: 2462948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Asthma and airway inflammation: potential anti-inflammatory activities of phosphodiesterase inhibitors.
    Lagente V; Hichami A; Boichot E; Martins MA; Silva PM
    Allerg Immunol (Paris); 1995 Feb; 27(2):34-9. PubMed ID: 7710653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of cyclic AMP phosphodiesterase (PDE4) reverses memory deficits associated with NMDA receptor antagonism.
    Zhang HT; Crissman AM; Dorairaj NR; Chandler LJ; O'Donnell JM
    Neuropsychopharmacology; 2000 Aug; 23(2):198-204. PubMed ID: 10882846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Congenital nephrogenic diabetes insipidus in a baby girl.
    Schreiner RL; Skafish PR; Anand SK; Northway JD
    Arch Dis Child; 1978 Nov; 53(11):906-8. PubMed ID: 215090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.